The regulation of IGFs and IGFBPs by prolactin in primary culture of fetal rat hepatocytes is influenced by maternal malnutrition

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 4, 2006, Pages

  El Khattabi, Ilham ^a   Remacle, Claude ^a   Reusens, Brigitte ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Fetal hepatocytes; Insulin like growth factor binding proteins; Insulin like growth factors; Low protein diet

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FETUS; GESTATION PERIOD; LIVER CELL; MALE; MALNUTRITION; MATERNAL WELFARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RESTRICTION; RAT;

ANIMALS; BLOTTING, WESTERN; CELL GROWTH PROCESSES; CULTURE MEDIA, CONDITIONED; DIETARY PROTEINS; FEMALE; FETAL DEVELOPMENT; HEPATOCYTES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIVER; MALE; MALNUTRITION; PREGNANCY; PROLACTIN; RANDOM ALLOCATION; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33749264783     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00509.2005     Document Type: Article

References (57)

1. Barash I, Cromlish W, and Posner BI. Prolactin receptor induction in cultured rat hepatocytes: dual regulation by prolactin and growth hormone. Endocrinology 122: 1151-1158, 1988.
2. Ben-Jonathan N, Mershon JL, Allen DL, and Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17: 639-650, 1996.
3. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, and Edery M. The short form of the prolactin (PRL) receptor silences PRL induction of the β-casein gene promoter. Mol Endocrinol 11: 1449-1457, 1997.
4. Binart N, Imbert-Bolloré P, Baran N, Viglietta C, and Paul A. A short form of the Prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor Mice. Mol Endocrinol 17: 1066-1074, 2003.
5. Bole-Feysot C, Goffin V, Edery M, Binart N, and Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19: 225-268, 1998.
6. Boujendar S, Reusens B, Merezak S, Ahn MT, Arany E, Hill D, and Remacle C. Taurine supplementation to a low protein diet during fetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets. Diabetologia 45: 856-866, 2002.
7. Brelje TC, Scharp DW, Lacy PE, Ogren L, Talamantes F, Robertson M, Friesen HG, and Sorenson RL. Effects of homologous placental lactogenes, prolactins and growth hormones on islet β cell division and insulin secretion in rat, mouse and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology 132: 879-887, 1993.
8. Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Jan T, Dey SK, Dotto PG, and Weinberg RA. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell 3: 877-887, 2002.
9. Butler AA and Le Roith D. Minireview: tissue-specific versus generalized gene targeting of the igf1 and igf1r genes and their roles in insulin-like growth factor physiology. Endocrinology 142: 1685-1688, 2001.
10. Currie MJ, Bassett NS, Breier BH, Klempt M, Min SH, Mackenzie DD, McCutcheon SN, and Gluckman PD. Differential effects of maternal ovine placental lactogen and growth hormone (GH) administration on GH receptor, insulin-like growth factor (IGF)-1 and IGF binding protein-3 gene expression in the pregnant and fetal sheep. Growth Regul 6: 123-129, 1996.
11. Das R and Vonderhaar BK. Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol Endocrinol 9: 1750-1759, 1995.
12. Daughaday WH and Rotwein P. Insulin-like growth factors -I and -II: peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10: 68-91, 1989.
13. El Khattabi I, Grégoire F, Remacle C, and Reusens B. Isocaloric maternal low-protein diet alters IGF-I, IGFBPs, and hepatocyte proliferation in the fetal rat. Am J Physiol Endocrinol Metab 285: E991-E1000, 2003.
14. Fielder PJ, Thordarson G, English A, Rosenfeld RG, and Talamantes F. Expression of a lactogen-dependent insulin-like growth factor-binding protein in cultured mouse mammary epithelial cells. Endocrinology 131: 261-267, 1992.
15. Freemark M, Kirk K, Pihoker C, Robertson MC, Shiu RP, and Driscoll P. Pregnancy lactogens in the rat conceptus and fetus: circulating levels, distribution of binding, and expression of receptor messenger ribonucleic acid. Endocrinology 133: 1830-1842, 1993.
16. Freemark M, Driscoll P, Maaskant R, Petryk A, and Kelly PA. Ontogenesis of prolactin receptors in the human fetus in early gestation: implications for tissue differentiation and development. J Clin Invest 99: 1107-1117, 1997.
17. Freemark M. Ontogenesis of prolactin receptors in the human fetus: roles in fetal development. Biochem Soc Trans 29: 38-41, 2001.
18. Gluckman PD and Pinal CS. Regulation of fetal growth by the somatotrophic axis. J Nutr 133: 1741S-1746S, 2003.
19. Goffin V, Shiverich KT, Kelly PA, and Martial JA. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 17: 385-410, 1996.
20. Goffin V, Binart N, Clement-Lacroix P, Bouchard B, Bole-Feysot C, Edery M, Lucas BK, Touraine P, Pezet A, Maaskant R, Pichard C, Helloco C, Baran N, Favre H, Bernichtein S, Allamando A, Ormandy C, and Kelly PA. From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. Genet Anal 15: 189-201, 1999.
21. Goodyer CG, Figueiredo RMO, Krackovitch S, Li LD, Manalo JA, and Zogopoulos G. Characterization of the growth hormone receptor in human dermal fibroblasts and liver during development. Am J Physiol Endocrinol Metab 281: E1213-E1220, 2001.
22. Goya L, Rivero F, Martin MA, Arahuetes R, Hernandez ER, and Pascual-Leone AM. Effects of refeeding of undernourished and insulin treatment of diabetic neonatal rats on IGF and IGFBP. Am J Physiol Endocrinol Metab 271: E223-E231, 1996.
23. Goya L, de la Puente A, Ramos S, Martin MA, Escriva F, Alvarez C, and Pascual-Leone AM. Regulation of IGF-I and -II by insulin in primary cultures of fetal rat hepatocytes. Endocrinology 142: 5089-5096, 2001.
24. Gruppuso PA, Awad M, Bienieki TC, Boylan JM, Fernando S, and Faris RA. Modulation of mitogen-independent hepatocyte proliferation during the perinatal period in the rat. In Vitro Cell Dev Biol Anim 33: 562-568, 1996.
25. Hill DJ, Camacho-Hubner C, Rashid P, Strain AJ, and Clemmons DR. Insulin-like growth factor (IGF)-binding protein release by fetal fibroblasts: dependency on cell density and IGF peptides. J Endocrinol 122: 87-98, 1989.
26. Hill DJ, Petrik J, and Arany E. Growth factors and the regulation of fetal growth. Diabetes Care 21: B60-B69, 1998.
27. Holt RI. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab 13: 392-397, 2002.
28. Hossenlopp PD, Seurin B, Segovia-Quinson S, Hardouin, and Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138-143, 1986.
29. Hyatt MA, Walker DA, Stephenson T, and Symonds ME. Ontogeny and nutritional manipulation of the hepatic prolactin-growth hormone-insulin-like growth factor axis in the ovine fetus and in neonate and juvenile sheep. Proc Nutr Soc 63: 127-135, 2004.
30. Jahn GA, Daniel N, Jolivet G, Belair L, Bole-Feysot C, Kelly PA, and Djiane J. In vivo study of prolactin (PRL) intracellular signaling during lactogenesis in the rat: JAK/STAT pathway is activated by PRL in the mammary gland but not in the liver. Biol Reprod 57: 894-900, 1997.
31. Karabulut AK and Pratten MK. Species-specificity of growth-promoting effects of prolactin during rat embryogenesis. J Anat 192: 1-12, 1998.
32. Karabulut AK, Layfield R, and Pratten MK. The mechanism of growth-promoting effects of prolactin in embryogenesis: links to growth factors. Cells Tissues Organs 164: 2-13, 1999.
33. Karabulut AK, Layfield R, and Pratten MK. Growth promoting effects of human placental lactogen during early organogenesis: link to insulin-like growth factors. J Anat 198: 651-662, 2001.
34. Lassare C, Hardouin S, Daffos F, Forestier F, Frankenne F, and Binoux M. Serum IGFs and IGFBPs in the human fetus. Relationships with growth in normal subjects with intrauterine growth retardation. Pediatr Res 29: 219-225, 1991.
35. Le Roith D. The insulin-like growth factor system. Exp Diabesity Res 4: 205-212, 2003.
36. Li J, Saunders JC, Fowden AL, Dauncey MJ, and Gilmour RS. Transcriptional regulation of insulin-like growth factor-II gene expression by cortisol in fetal sheep during late gestation. J Biol Chem 273: 10586-10593, 1998.
37. Liu JP, Baker J, Perkins AS, Robertson EJ, and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-I) and the type 1 IGF receptor (Igf1r). Cell 75: 59-72, 1993.
38. Melnikova VI, Orosco M, Rouch C, Calas A, Nicolaidis S, Proshlyakova EV, Sapronova AY, and Ugrumov MV. Prolactin secretion and its dopamine inhibitory control in rat fetuses. Eur J Endocrinol 139: 337-342, 1998.
39. Menuelle P, Babajko S, and Plas C. Insulin-like growth factor (IGF) binding proteins modulate the glucocorticoid-dependent biological effects of IGF-II in cultured fetal rat hepatocytes. Endocrinology 140: 2232-2240, 1999.
40. Murphy LJ, Tachibana K, and Friesen HG. Stimulation of hepatic insulin-like growth factor-I gene expression by ovine prolactin: evidence for intrinsic somatogenic activity in the rat. Endocrinology 122: 2027-2033, 1988.
41. Murphy LJ. Overexpression of insulin-like growth factor binding protein-1 in transgenic mice. Pediatr Nephrol 14: 567-571, 2000.
42. Nemeskeri A, Acs Z, and Toth BE. Prolactin-synthesizing and prolactin-releasing activity of fetal and early postnatal rat pituitaries: in vivo and in vitro studies using RIA, reverse haemolytic plaque assay and immunocytochemistry. Neuroendocrinology 61: 687-694, 1995.
43. Okamura H, Zachweija J, Raguet S, and Kelly PA. Characterization and application of monoclonal antibodies to the PRL receptor. Endocrinology 124: 2499-2508, 1989.
44. Oliver MH, Harding JE, Breier BH, Evans PC, Gallaher BW, and Gluckman PD. The effects of ovine placental lactogen infusion on metabolites, insulin-like growth factors and binding proteins in the fetal sheep. J Endocrinol 144: 333-338, 1995.
45. Ouhtit A, Ronsin B, Kelly PA, and Morel G. Ultrastructural expression of prolactin receptor in rat liver. Biol Cell 82: 169-176, 1994.
46. Perrot-Applanat M, Guallillo O, Pezet A, Vincent V, Edery M, and Kelly PA. Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol 11: 1020-1032, 1997.
47. Petrik J, Reusens B, Arany E, Remacle C, Coelho C, Hoet JJ, and Hill DJ. A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. Endocrinology 140: 4861-4873, 1999.
48. Phillips ID, Anthony RV, Simonetta G, Owens JA, Robinson JS, and McMillen IC. Restriction of fetal growth has a differential impact on fetal prolactin and prolactin receptor mRNA expression. J Neuroendocrinol 13: 175-181, 2001.
49. Phillips K, Park MA, Auarrie LH, Boutinaud M, Locherie JD, Flint DJ, Allan GJ, and Beattie J. hormonal control of IGF-binding protein (IGFBP)-5 and IGFBP-2 secretion during differentiation of the HC11 mouse mammary epithelial cell line. J Mol Endocrinol 31: 197-208, 2003.
50. Rivero F, Goya L, Alaez C, and Pascual-leone AM. Effects of undernutrition and diabetes on serum and liver mRNA expression of IGFs and their binding proteins during rat development. J Endocrinol 145: 427-440, 1995.
51. Robertson MC, Cosby H, Fresnoza A, Cattini PA, Shiu RP, and Friesen HG. Expression, purification, and characterization of recombinant rat placental lactogen-I: a comparison with the native hormone. Endocrinology: 393-400, 1994.
52. Saunier E, Dif F, Kelly PA, and Edery M. Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology 144: 2669-2674, 2003.
53. Seyoum G, Robertson MC, Persaud TV, Paterson JA, and Shiu RP. Influence of rat placental lactogen-I on the development of whole rat embryos in culture. J Endocrinol 160: 231-237, 1999.
54. Snoeck A, Remacle C, Reusens B, and Hoet JJ. Effect of low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 57: 107-118, 1990.
55. Strauss DS, Ooi GT, Orlowski CC, and Rechler MM. Expression of the genes for insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins-1 and -2 in fetal rat under conditions of intrauterine growth retardation caused by maternal fasting. Endocrinology 128: 518-525, 1991.
56. Symonds ME, Budge H, Stephenson T, and McMillen IC. Fetal endocrinology and development - manipulation and adaptation to long-term nutritional and environmental challenges. Reproduction 121: 853-862, 2001.
57. Wollmann HA. Growth hormone and growth factors during perinatal life. Horm Res 53, Suppl 1: 50-54, 2000.